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What is medicine? What is physical science? Can one
really place limitations on the realm of experimentation
or modeling in any particular discipline? A potential an-
swertosomeofthesequestionsisactuallybasedonsimple
molecular physics. Which for the last several years (since
the advent of powerful supercomputers) has been a rela-
tively neglected area in biomedical research.
Through the understanding of chemical interactions,
many medical discoveries can be approached. For exam-
ple, if one is trying to ﬁnd a molecular substance that may
potentiallysuppressaparticulartypeofcancercellgrowth
fromaseriesofstructures,thismayeasilybedonebyﬁnd-
ing structures with particular electrostatic potential prop-
erties. A quantum chemical computational study can be
performed, and a structure ready for laboratory studies
can be found within a matter of hours (if the structure is
modest in size, 100–few hundred atoms).
Other more intriguing investigations can even make
use of the chiral properties of certain molecular species.
If one would like to characterize the binding of a trans-
activator such as Tat to HIV-1, one may argue that many
isomeric and stereo-competitive forms exist, yet only one
may be naturally occurring (with a higher probability)
and hence more practically useful.
An example of how important this concept may be
from an isomeric point of view is the bodies’ response to
isopropanol versus ethanol. From the stereospeciﬁc point
of view, other examples commonly encountered include
the competition between the two forms glucose (D-, and
L-) exist, yet only one can be favorably used by our sys-
tems.
In the problem of HIV-1 suppression (or any other
type of viral disease), one can use computational meth-
ods to ﬁrst optimize (by some kind of molecular mechan-
ics or dynamics methods) the two structures (HIV-1 and
Tat), calculating their relative energies (HIV-1 relative to
Tat since it is larger, and Tat can be given a value of zero).
Next, the dealer (perhaps even the biologist or medical
doctor!) can ﬁnd several orientations (based on chirality,
and other physical properties) of the HIV-1/Tat complex.
The lowest in energy is thermodynamically favorable, and
is an observable in nature. This can be completely exper-
imentally and theoretically characterized (ie, via partition
functions, heat capacities, vibrational energies, etc).
But how can this aﬀect anyone undergoing treatment?
Simple, now you know the physical basis for the interac-
tion,thenextstepistoﬁndamediator compoundtobreak
up this interaction. If we know that C261 is needed by Tat
to bind to HIV-1 (more speciﬁcally the TAR region), one
can simply locate (by a potential energy surface calcula-
tion)severalanaloguesofamoleculeintothemixture(the
HIV-1/Tat complex), and calculate the relative energy. If
the energy is very high, then the chances of forming it are
nearly zero. If the energy is very low, then the mediator
forms the desired target interaction (in this case suppres-
sion of Tat binding to HIV-1). The point of this is that
physical methods can easily make their way into routing
practices of biomedicine and biotechnology research.
One may ask how can these calculations be done
on so large polymers? Consider the general form of
the total energy of interacting ions and electrons as
Etot = Ee-e +E e-ion +E ion-ion. We can see from this simple
interaction that the total energy is a sum of the kinetic
energy of the interactions between the electrons, the sum
of the potential energy of the interaction between the ion
and electron, and the energy of the interaction between
the ions. If we can then, average out all interactions with a
density of a particular group (ie, Cysteine, tyrosine, etc),
we can easily compute the energies of even the largest
complexes by using densities, which is fairly easy to do
once the corresponding groups are well characterized (the
amino acid chain sequences).
Even statistical thermodynamics and mechanics allow
for any useful medical data to be obtained. It has been
shown recently that understanding of the evolution of the
composition and structure of living beings can be based
on the thermodynamic study of hierarchic structures at
diﬀerent levels.
Consider the second law of thermodynamics, which
is one of the general laws of nature that deﬁnes direction
and completeness (degree of transformation or extent of
a process) of the real thermodynamic processes. It states
that the entropy of a system will increase (in an isolated
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processes increases. However, biosystems are continu-
ously “fed” by energy-rich compounds synthesized in
nonspontaneous processes. From this viewpoint, biosys-
tems do not spontaneously “move away” from some
“vague equilibrium,” as is generally accepted, but rather
exist in a stationary state of matter circulation. In this rel-
ative circulation, the thermodynamically unstable com-
pounds are continuously generated upon exposure to an
external energy source. Obviously, the sun, which is not
only an external energy source but it is primary to exis-
tence, is the driving force of nonspontaneous processes
of matter circulation on earth (although other energy
sources exist as well, such as atmospheric discharges, vol-
canic activity, etc).
For most cases, however, thermodynamic results do
allow for the calculations of the spontaneous degrada-
tionofbiomoleculesthatresultsinthe“recovery”ofcom-
pounds that are thermodynamically stable (under earth
conditions) into the matter exchange cycle, making them
a routine in a variety of biologically related problems. If
wearegoingtoobtainaprobablestructurefromquantum
mechanics, thermodynamics is then needed to character-
ize this complex by computing various physical proper-
ties.
All in all, practical medical problems are becoming
an area of interest to many branches of physical science
research. Quantum and statistical mechanics are making
their way into many modern experimental research labs,
and are deeply impacting the way by which many do re-
search. They allow for a very rapid comparison of many
potential drug agents without wasting the time, energy,
and resources needed for preliminary test runs. Although,
the era of computational drug design and bioquantum
mechanics is just beginning to make its way up to the sci-
entiﬁcladder,thereissomuchpotentialforitsuseandap-
plicationsthatitisdeﬁnitelyanareawheremanyscientists
needtobegintomakesomeseriousinvestmentstomaster
these methods. Modern resources make it possible for the
original formulations of Schr¨ odinger, Hartree, Fermi, and
others to be put to the test of more practical open-ended
problems. Just as the early physicists were put to the test
of developing models to understand fundamental ques-
tions of nature, today’s scientists are given the prospect of
usingoldtoolsinanextremelynovelcontext.Onlythefu-
ture will tell how far this dream will be fulﬁlled. So what is
medicine,orscienceforthatmatter?Theanswerissimple.
Life.
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